EAM
LEGN icon

EFG Asset Management’s Legend Biotech LEGN Stock Holding History

EFG Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-59,078
Closed -$2.88M – 190
2024
Q3 		$2.88M Sell
59,078
-12,001
-17% -$639K 0.48% 77
2024
Q2 		$3.15M Buy
71,079
+1,820
+3% +$84K 0.55% 56
2024
Q1 		$3.89M Buy
69,259
+9,001
+15% +$543K 0.67% 41
2023
Q4 		$3.63M Sell
60,258
-11,814
-16% -$749K 0.69% 49
2023
Q3 		$4.84M Sell
72,072
-9,041
-11% -$628K 1.15% 21
2023
Q2 		$5.6M Sell
81,113
-28,243
-26% -$1.85M 1.2% 14
2023
Q1 		$5.28M Buy
109,356
+7,176
+7% +$351K 1.17% 21
2022
Q4 		$5.08M Buy
102,180
+11,052
+12% +$535K 1.14% 19
2022
Q3 		$3.72M Sell
91,128
-7,880
-8% -$370K 0.86% 41
2022
Q2 		$5.45M Sell
99,008
-3,636
-4% -$154K 1.15% 22
2022
Q1 		$3.73M Buy
102,644
+24,926
+32% +$985K 0.56% 57
2021
Q4 		$3.62M Buy
+77,718
New +$3.94M 0.47% 60

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EFG Asset Management's LEGN Position: Q4 2024 in Review

EFG Asset Management sold out of Legend Biotech (LEGN) in Q4 2024, closing a stake of 59,078 shares — an estimated $2.88M sold.

EFG Asset Management first reported a position in LEGN in Q4 2021 and held it in 12 quarters. The position peaked at $5.6M in Q2 2023. 210 funds tracked by Wall St. Rank hold LEGN as of Q4 2024.

  • EFG Asset Management reported no remaining Legend Biotech position as of Q4 2024 after selling out during the quarter.
  • EFG Asset Management sold 59,078 Legend Biotech shares in Q4 2024, an estimated $2.88M.
  • EFG Asset Management first reported a position in Legend Biotech in Q4 2021 and held it in 12 quarters.
  • EFG Asset Management's Legend Biotech position peaked at $5.6M in Q2 2023.
  • 210 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2024.

Based on EFG Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.